DEER PARK, Ill., Feb. 06, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare…Original Article
You may also like
Depemokimab Applications Accepted for Review by the US...
FDA Files Corcept’s New Drug Application for...
Tolebrutinib Regulatory Submission Accepted for...
Capricor Therapeutics Announces FDA Acceptance and...
FDA Issues Complete Response Letter for Etripamil for...
FDA Grants Priority Review for Biologics License...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.